By Mill Chart
Last update: Sep 22, 2022
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Ticker | Change | Comment |
---|---|---|
SPRO | 168.0% | SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 168.0% to a price of $2.2. In the last 6 months the share price dropped with 89.92%. |
BOA.W | 105.0% | BOA ACQUISITION CL A -CW28 (NYSE:BOA.W) rose 105.0% to $0.14 during Thursday's after hours session. Shareholders saw the stock price going 65.5% lower in the past 3 months. |
ATXI | 92.33% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price is advancing with 92.33% to a price of $0.41. The stock is trading 65.23% lower than 6 months ago. |
AVCT | 48.35% | AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price is advancing with 48.35% to a price of $0.32. The stock is trading 53.27% higher than a month ago. |
AVCTW | 46.4% | PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) stock price is advancing with 46.4% to a price of $0.07. In the last 3 months the share price increased with 30.59%. |
SAVA | 29.12% | CASSAVA SCIENCES INC's (NASDAQ:SAVA) stock price increased by 29.12% to $48.6. In the last month the stock gained 48.72%. |
SONN | 28.79% | SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price increased by 28.79% to $1.7. In the last month the stock lost 60.53%. |
GSMGW | 26.42% | GLORY STAR NEW -CW25's (NASDAQ:GSMGW) stock price increased by 26.42% to $0.02. In the last 3 months the share price increased with 78.65%. |
BEAT | 24.68% | HEARTBEAM INC's (NASDAQ:BEAT) shares rose 24.68% to $1.97 during Thursday's session. The stock is trading 20.61% higher than a month ago. |
PIXY | 22.18% | SHIFTPIXY INC's (NASDAQ:PIXY) stock price increased by 22.18% to $16.69. Shareholders saw the stock price going 41.32% lower in the past month. |
For the full top gainers list go to our top gainers screener.
Ticker | Change | Comment |
---|---|---|
MOHO | -46.79% | ECMOHO LTD's (NASDAQ:MOHO) shares fell 46.79% to $0.09 during Thursday's session. The stock is trading 31.61% lower than 6 months ago. |
TOPS | -23.9% | TOP SHIPS INC's (NASDAQ:TOPS) stock price decreased by 23.9% to $0.16. Shareholders saw the stock price going 29.7% lower in the past month. |
SOBR | -23.43% | SOBR SAFE INC's (NASDAQ:SOBR) stock price is declining with 23.43% to a price of $1.83. In the last month the share price increased with 115.0%. |
OPP- | -23.08% | River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) shares fell 23.08% to $0.0. In the last month the share price dropped with 97.61%. |
AYLA | -20.0% | AYALA PHARMACEUTICALS INC's (NASDAQ:AYLA) stock price is declining with 20.0% to a price of $0.88. In the last 6 months the share price dropped with 73.24%. |
CPTN | -19.38% | CEPTON INC's (NASDAQ:CPTN) shares fell 19.38% to $1.69 during Thursday's session. A press release (Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology) was released yesterday. |
LAZR | -18.79% | LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 18.79% to $7.61. In the last 3 months the share price increased with 25.1%. |
AGRI | -18.64% | AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) stock price is declining with 18.64% to a price of $1.44. Shareholders saw the stock price going 29.2% lower in the past 3 months. |
HSDT | -18.41% | HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) shares fell 18.41% to $0.36. In the last month the share price dropped with 38.41%. |
JCSE | -16.67% | JE CLEANTECH HOLDINGS LTD's (NASDAQ:JCSE) shares fell 16.67% to $0.95 during Thursday's session. The stock is trading 40.93% lower than a month ago. |
Our top losers screener will show you the full list.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/24/2024, 4:35:37 PM)
1.42
-0.02 (-1.05%)
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...